Stay updated with breaking news from Nasdaq Impl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Impel Pharmaceuticals (NASDAQ:IMPL – Get Rating) is scheduled to release its earnings data before the market opens on Friday, May 12th. Impel Pharmaceuticals Stock Up 12.6 % NASDAQ IMPL opened at $2.60 on Friday. The company has a market capitalization of $61.75 million, a P/E ratio of -0.57 and a beta of -0.26. Impel Pharmaceuticals […]
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 389,700 shares, a growth of 17.1% from the March 31st total of 332,800 shares. Based on an average daily trading volume, of 42,800 shares, […]
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 389,700 shares, a growth of 17.1% from the March 31st total of 332,800 shares. Currently, 5.1% of the company’s shares are sold short. Based on an average […]
New Analysis Indicates No Drug-Drug Interactions (DDIs) of Clinical Concern are Predicted When Recommended Doses of Trudhesa and Gepants are...
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating)’s share price dropped 2.8% during trading on Monday . The stock traded as low as $1.74 and last traded at $1.77. Approximately 10,438 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 41,313 shares. The stock had previously closed at $1.82. […]